0000899243-23-001039.txt : 20230105 0000899243-23-001039.hdr.sgml : 20230105 20230105181802 ACCESSION NUMBER: 0000899243-23-001039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221222 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parkinson David Ross CENTRAL INDEX KEY: 0001451935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 23512854 MAIL ADDRESS: STREET 1: C/O THRESHOLD PHARMACEUTICALS, INC. STREET 2: 170 HARBOR WAY SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-22 0 0001633932 ESSA Pharma Inc. EPIX 0001451935 Parkinson David Ross C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720 VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA 1 1 0 0 Chief Executive Officer Common Shares 2022-12-22 4 P 0 21367 2.39 A 53475 D Common Shares 2022-12-30 4 P 0 3067 2.60 A 56542 D The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan. /s/ David Parkinson 2023-01-03